NCT02784977

Brief Summary

Primary aim of the TURKAPNE (The Turkish Sleep Apnea Database) study is to generate a cross-sectional nationwide database to define clinical and polysomnographic characteristics of the sleep apnea patients in Turkey. Associations of phenotypes of sleep apnea patients with metabolic and cardiovascular diseases as well as risk for traffic accidents will be explored as secondary aims. Impact of treatment of sleep apnea on metabolic and cardiovascular complications as well as compliance with positive airway pressure treatment will be further explored longitudinally.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10,000

participants targeted

Target at P75+ for all trials

Timeline
20mo left

Started Oct 2017

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress84%
Oct 2017Dec 2027

First Submitted

Initial submission to the registry

May 18, 2016

Completed
9 days until next milestone

First Posted

Study publicly available on registry

May 27, 2016

Completed
1.4 years until next milestone

Study Start

First participant enrolled

October 3, 2017

Completed
7.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2024

Completed
3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2027

Expected
Last Updated

October 13, 2022

Status Verified

October 1, 2022

Enrollment Period

7.2 years

First QC Date

May 18, 2016

Last Update Submit

October 12, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Metabolic and cardiovascular diseases in obstructive sleep apnea phenotypes

    The association of sleep apnea severity indices such as Apnea-Hypopnea Index and Oxygen Desaturation Index during Rapid Eye Movement (REM) sleep and non-REM sleep with self-reported diabetes mellitus and cardiovascular diseases will be explored.

    Up to three years

Secondary Outcomes (3)

  • Sex differences in obstructive sleep apnea phenotypes

    Up to three years

  • Adherence to positive airway pressure treatment in obstructive sleep apnea

    Through study completion, an average of 7 years

  • Incidence of cardiovascular diseases and mortality

    Through study completion, an average of 7 years

Study Arms (2)

Obstructive Sleep Apnea (OSA)

Patients with apnea hypopnea index of at least 5 events per hour. Intervention with positive airway pressure, or intraoral device, or uvuloplasty, or conservative treatment.

Device: Positive Airway Pressure (PAP)Device: Intraoral device (IOD)Procedure: UvuloplastyOther: Conservative treatment

No-OSA

Patients with apnea hypopnea index less than 5 events per hour. No intervention.

Interventions

Treatment of OSA with PAP

Obstructive Sleep Apnea (OSA)

Treatment of OSA with IOD

Obstructive Sleep Apnea (OSA)
UvuloplastyPROCEDURE

Uvuloplasty

Obstructive Sleep Apnea (OSA)

No active intervention

Obstructive Sleep Apnea (OSA)

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

All consecutive patients referred to the sleep clinics for suspicion of sleep apnea

You may qualify if:

  • Consecutive adult patients undergoing sleep study for suspicion of obstructive sleep apnea
  • Ability to read and speak
  • Signed informed consent.

You may not qualify if:

  • subjects who use positive airway pressure
  • subjects with limited life expectancy due to advanced renal disease or uncontrolled malignancies
  • subjects with alcohol dependency

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Koç University Hospital

Istanbul, TR 34010, Turkey (Türkiye)

RECRUITING

Related Publications (2)

  • Peker Y, Basoglu OK, Firat H; TURKAPNE Study Group. Rationale and Design of the Turkish Sleep Apnea Database - TURKAPNE: A National, Multicenter, Observational, Prospective Cohort Study. Turk Thorac J. 2018 Jul;19(3):136-140. doi: 10.5152/TurkThoracJ.2018.18097. Epub 2018 Jul 1.

    PMID: 30083405BACKGROUND
  • Pihtili A, Kiyan E, Balcan B, Arbatli S, Cilli A, Altintas N, Ugurlu AO, Gurkan CG, Tasbakan MS, Dursunoglu N, Ogun H, Annakkaya AN, Sokucu SN, Firat H, Basoglu OK, Peker Y; Turkapne Study Group. Sex differences in clinical and polysomnographic features of obstructive sleep apnea: The Turkish sleep apnea database (TURKAPNE) cohort. Sleep Med. 2025 Feb;126:228-234. doi: 10.1016/j.sleep.2024.12.018. Epub 2024 Dec 17.

MeSH Terms

Conditions

Sleep Apnea, Obstructive

Interventions

Conservative Treatment

Condition Hierarchy (Ancestors)

Sleep Apnea SyndromesApneaRespiration DisordersRespiratory Tract DiseasesSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System Diseases

Intervention Hierarchy (Ancestors)

Therapeutics

Study Officials

  • Yüksel Peker, Prof

    Koç University School of Medicine, Dept of Pulmonary Medicine

    STUDY CHAIR
  • Özen Kacmaz Basoglu, Prof

    Ege University School of Medicine

    PRINCIPAL INVESTIGATOR
  • Hikmet Firat, Assoc. Prof

    Ankara Diskapi Yildirim Beyazit Education and Research Hospital

    PRINCIPAL INVESTIGATOR
  • Oya Itil, Prof

    Dokuz Eylul University Medical School

    PRINCIPAL INVESTIGATOR
  • Mehmet Karadag, Prof

    Uludag University Medical School

    PRINCIPAL INVESTIGATOR
  • Nejat Altintas, Assoc. Prof

    Namik Kemal University Medical School

    PRINCIPAL INVESTIGATOR
  • Gökhan Kirbas, Prof

    Dicle University Medical School

    PRINCIPAL INVESTIGATOR
  • Önder Öztürk, Assoc. Prof

    Süleyman Demirel University Medical School

    PRINCIPAL INVESTIGATOR
  • Derya Karadeniz, Prof

    Istanbul University Cerrahpasa Medical School

    PRINCIPAL INVESTIGATOR
  • Nese Dursunoglu, Assoc. Prof

    Pamukkale University Medical School

    PRINCIPAL INVESTIGATOR
  • Gundeniz Altiay, Prof

    Trakya University Medical School

    PRINCIPAL INVESTIGATOR
  • Ersin Günay, Assoc. Prof

    Afyon Kocatepe University Medical School

    PRINCIPAL INVESTIGATOR
  • Sema Sarac, MD

    Istanbul Sureyyapasa Education and Research Hospital

    PRINCIPAL INVESTIGATOR
  • Zahide Yilmaz, MD

    Kocaeli Education and Research Hospital

    PRINCIPAL INVESTIGATOR
  • Aylin Ozsancak Ugurlu, Assoc. Prof

    Istanbul Baskent University Hospital

    PRINCIPAL INVESTIGATOR
  • Kadriye Agan Yildirim, Prof

    Marmara University, Faculty of Medicine, Department of Neurology

    PRINCIPAL INVESTIGATOR
  • Sertac Arslan, Assist Prof

    Corum Hitit University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Yüksel Peker, Prof

CONTACT

Baran Balcan, Assoc. Prof

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
10 Years
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 18, 2016

First Posted

May 27, 2016

Study Start

October 3, 2017

Primary Completion

December 31, 2024

Study Completion (Estimated)

December 31, 2027

Last Updated

October 13, 2022

Record last verified: 2022-10

Data Sharing

IPD Sharing
Will not share

Locations